Back to
Allianz Asset Management GmbH
IOVA
Showing 2 of 25 quarters
Position history for
Allianz Asset Management GmbH's holdings in IOVANCE BIOTHERAPEUTICS INC
No. Allianz Asset Management exited its IOVA (Iovance Biotherapeutics) position in Q2 2025. Its Q1 2025 13F listed 20,300 shares worth $67,599. Allianz Asset Management already held IOVA in its Q4 2018 13F, the earliest on record, and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$67,599
Total Shares Change
-20,300
Quarter-by-Quarter History